Window Trial 5-aza in HNSCC, T-tare
NCT02178072
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
DRUG:
5-Azacitadine
Sponsor
Yale University